Burden of treatment for chronic illness: a concept analysis and review of the literature.
Adem Sav, Michelle A King, Jennifer A Whitty...
https://pubmed.ncbi.nlm.nih.gov/23363080/Actively Recruiting
Led by Rigshospitalet, Denmark · Updated on 2025-07-24
200
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are studying patient preferences for receiving intravitreal dexamethasone implant injections Ozurdex in both eyes on the same day in the same session. This approach is relevant for people with diabetic macular edema, macular edema from retinal vein occlusion, or noninfectious posterior uveitis. The study focuses on how personal and socio-economic factors influence patients choices and aims to improve patient experience and resource use in clinical care. The treatment being evaluated is the intravitreal dexamethasone implant Ozurdex given according to manufacturer recommendations. The study observes patients who have already received this implant in either eye, exploring their preferences regarding bilateral same-day injections. The research is observational and does not involve experimental treatment changes, focusing instead on gathering patient perspectives over about 9 months. Participants will provide information through questionnaires to identify their injection preferences and the reasons behind them. Researchers will also collect data on patient characteristics and socio-economic variables to understand differences between preference groups. The main outcome measured is the preference for bilateral injections during the study period. The study runs until early 2026 and is sponsored by Rigshospitalet, Denmark.
CONDITIONS
Patient Preferences on Same-day Bilateral Intravitreal Dexamethasone Injections
L
Lena Michelle Mørup Andersen, MScN
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Rigshospitalet, Denmark
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Approximately 9 months
Participants who have previously received intravitreal dexamethasone implants are observed to assess their preferences and other related outcomes over time.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Adem Sav, Michelle A King, Jennifer A Whitty...
https://pubmed.ncbi.nlm.nih.gov/23363080/Russel H Dinh, Obadah Moushmoush, Peter Kolyvas...
https://pubmed.ncbi.nlm.nih.gov/36378615/Jonathan Malcolm, Christopher Leak, Alexander C Day...
https://pubmed.ncbi.nlm.nih.gov/35859120/John F P Bridges, Esther W de Bekker-Grob, Brett Hauber...
https://pubmed.ncbi.nlm.nih.gov/36754539/Tai-Chi Lin, Po-Chen Tseng, Tsui-Kang Hsu...
https://pubmed.ncbi.nlm.nih.gov/37552956/Vinit B Mahajan, Kori A Elkins, Stephen R Russell...
https://pubmed.ncbi.nlm.nih.gov/21187731/Kapil G Kapoor, James B Colchao
https://pubmed.ncbi.nlm.nih.gov/29155696/Mor M Dickman, Lindsay S Spekreijse, Bjorn Winkens...
https://pubmed.ncbi.nlm.nih.gov/35467755/Rigshospitalet, Denmark
Lead Sponsor